Apellis Pharmaceuticals, Inc

(NASDAQ:APLS)

Latest On Apellis Pharmaceuticals, Inc (APLS):

Date/Time Type Description Signal Details
2023-05-25 17:48 ESTNewsApellis and Sobi to drop ALS candidate on Phase 2 setbackN/A
2023-05-18 17:01 ESTNewsApellis Pharmaceuticals: Biotech's Rising Star In C3 Inhibition SpaceN/A
2023-05-06 12:27 ESTNewsApellis Pharmaceuticals, Inc. 2023 Q1 - Results - Earnings Call PresentationN/A
2023-05-06 12:27 ESTNewsApellis Pharmaceuticals, Inc. (APLS) Q1 2023 Earnings Call TranscriptN/A
2023-05-04 22:14 ESTNewsApellis Pharmaceuticals: Maintain 'Buy' Following Astellas' $5.9 Billion Acquisition Of Iveric BioN/A
2023-05-04 22:14 ESTNewsApellis Pharmaceuticals GAAP EPS of -$1.56 misses by $0.10, revenue of $44.84M beats by $18.74MN/A
2023-05-03 20:58 ESTNewsApellis Pharmaceuticals Q1 2023 Earnings PreviewN/A
2023-05-01 19:14 ESTNewsApellis weakness on Iveric Bio takeout is buying opportunity - analystN/A
2023-05-01 06:55 ESTNewsApellis Pharmaceuticals (APLS) Presents at the Association for Research in Vision and Ophthalmology Annual Meeting - SlideshowN/A
2023-04-03 17:26 ESTNewsApellis Pharmaceuticals may be worth $90-$100 a share in sale - analystN/A
2023-04-02 23:22 ESTNewsApellis Pharmaceuticals sees takeover interest from large pharma - BloombergN/A
2023-03-24 22:48 ESTNewsApellis Pharmaceuticals Is Poised For Dominance In Geographic Atrophy MarketN/A
2023-03-16 14:19 ESTNewsApellis Pharmaceuticals' Empaveli sNDA action date extended by FDAN/A
2023-02-23 11:44 ESTNewsApellis Pharmaceuticals prices $350M in stock offeringN/A
2023-02-22 09:58 ESTNewsApellis Pharmaceuticals to raise $300M in stock and warrants offeringN/A
2023-02-21 21:29 ESTNewsApellis Pharmaceuticals GAAP EPS of -$1.50 beats by $0.06, revenue of $22.66M misses by $1.86MN/A
2023-02-18 02:43 ESTNewsApellis wins FDA nod for eye disorder therapyN/A
2023-01-27 18:43 ESTNewsApellis: Empaveli Ought To Win Approval For Eye Disease In February - The Future Looks BrightN/A
2023-01-21 14:26 ESTNewsStocks To Watch: Earnings Heat Up, Healthcare Catalysts And M&A WildcardsN/A
2023-01-05 20:02 ESTNewsApellis appoints Baumal as Chief Medical OfficerN/A
2023-01-04 02:30 ESTNewsApellis, Arvinas lower as Wells Fargo downgrades in 2023 biotech previewN/A
2022-12-15 23:44 ESTNewsApellis Pharmaceuticals: Approval Is Baked Into ValuationN/A
2022-11-18 10:24 ESTNewsApellis surges 17% as FDA accepts to review new data in filing for eye disorder drugN/A
2022-11-11 06:07 ESTNewsApellis, IVERIC bio cut to Hold at Jefferies; says Street overestimates GA marketN/A
2022-11-08 08:01 ESTNewsApellis Pharmaceuticals GAAP EPS of -$1.75 misses by $0.29, revenue of $22.05M beats by $0.46MN/A
2022-11-08 08:00 ESTNewsApellis Pharmaceuticals, Inc. (APLS) Q3 2022 Earnings Call TranscriptN/A
2022-11-05 08:22 ESTNewsApellis Pharmaceuticals Q3 2022 Earnings PreviewN/A
2022-11-03 23:08 ESTNewsApellis sinks 20% as FDA review period for eye disease drug extendsN/A
2022-10-16 23:00 ESTNewsCiti lists four more value-creating events in biotech for this yearN/A
2022-09-29 06:33 ESTNewsApellis Pharmaceuticals: Trying To Develop A Blockbuster FranchiseN/A
2022-09-08 07:22 ESTNewsApellis gains as FDA says AdCom unnecessary for eye disease candidateN/A
2022-08-24 16:51 ESTNewsApellis stock dips amid 2-year data of pegcetacoplan for eye disorderN/A
2022-08-09 18:37 ESTNewsApellis Pharmaceuticals, Inc. 2022 Q2 - Results - Earnings Call PresentationN/A
2022-08-09 18:37 ESTNewsApellis Pharmaceuticals, Inc. (APLS) CEO Cedric Francois on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-08 18:56 ESTNewsApellis Pharmaceuticals GAAP EPS of -$1.46 misses by $0.09, revenue of $16.32M misses by $0.63MN/A
2022-08-06 06:05 ESTNewsApellis Pharmaceuticals Q2 2022 Earnings PreviewN/A
2022-07-27 15:50 ESTNewsApellis to exchange $75.6M in convertible senior notes for common stockN/A
2022-07-20 18:36 ESTNewsApellis Pharmaceuticals: The Meaning Of Priority Review For Pegcetacoplan For Geographic AtrophyN/A
2022-07-20 03:57 ESTNewsWainwright sees blockbuster potential for Apellis eye degeneration therapy; shares up 22%N/A
2022-07-19 13:21 ESTNewsApellis stock soars 24% as FDA grants priority review to pegcetacoplan for eye disorderN/A
2022-07-19 13:19 ESTNewsH.C. Wainwright sees blockbuster potential for Apellis' treatment in eye degenerationN/A
2022-06-25 15:25 ESTNewsApellis: Mixed Data, But Definitely Approvable In GAN/A
2022-06-13 19:55 ESTNewsHot Stocks: APLS & SKIL both gain, TSLA declined despite upgrade, and VLTA plungedN/A
2022-06-10 11:34 ESTNewsApellis/Sobi Empaveli shows benefit in rare blood disorder patients in new analysesN/A
2022-06-01 11:05 ESTNewsApellis files for FDA approval of pegcetacoplan to treat eye disorderN/A
2022-05-06 19:17 ESTNewsApellis Pharmaceuticals, Inc. 2022 Q1 - Results - Earnings Call PresentationN/A
2022-05-06 19:15 ESTNewsApellis Pharmaceuticals (APLS) Investor Presentation - SlideshowN/A
2022-05-04 22:43 ESTNewsApellis Pharmaceuticals GAAP EPS of -$1.42 misses by $0.12, revenue of $12.1M misses by $0.52MN/A
2022-05-04 22:42 ESTNewsApellis Pharmaceuticals, Inc. (APLS) CEO Cedric Francois on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-04 03:15 ESTNewsApellis Pharmaceuticals Q1 2022 Earnings PreviewN/A

About Apellis Pharmaceuticals, Inc (APLS):

Apellis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. Its lead product candidate is pegcetacoplan that is in Phase III clinical trials for the treatment of geographic atrophy in age-related macular degeneration and paroxysmal nocturnal hemoglobinuria (PNH) diseases; cold agglutinin disease; C3 glomerulopathy; and other glomerular diseases, such as IgA nephropathy, primary membranous nephropathy, and lupus nephritis. The company also develops APL-9, which is in single ascending dose Phase I randomized, double-blind, and placebo-controlled clinical trials for the prevention of immune system activation coincident with adeno-associated virus for intravenous administration, as well as is in Phase I/II clinical trial for acute respiratory distress syndrome. It has a collaboration and license agreement with Swedish Orphan Biovitrum AB (publ) to co-develop pegcetacoplan. The company was incorporated in 2009 and is based in Waltham, Massachusetts.

See Advanced Chart

General

  • Name Apellis Pharmaceuticals, Inc
  • Symbol APLS
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 374
  • Fiscal Year EndDecember
  • IPO Date2017-11-09
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.apellis.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 13.99
  • Price/Book (Most Recent Quarter) 18.33
  • Enterprise Value Revenue 12.97
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$6.46
  • Next Year EPS Estimate -$5.31
  • Next Quarter EPS Estimate -$1.60
  • Profit Margin -138%
  • Operating Margin -85%
  • Return on Assets -20%
  • Return on Equity -289%
  • Revenue 250.65 million
  • Earnings Per Share -$3.32
  • Revenue Per Share $3.34
  • Gross Profit -74325000
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 3.54 billion
  • Analyst Target Price $64.14
  • Book Value Per Share $2.69
View More

Share Statistics

  • Shares Outstanding 80.38 million
  • Shares Float 59.7 million
  • % Held by Insiders 2117%
  • % Held by Institutions 82.85%
  • Shares Short 8.11 million
  • Shares Short Prior Month 7.75 million
  • Short Ratio 13.44
  • Short % of Float 15%
  • Short % of Shares Outstanding 10%
View More

Technicals

  • Beta 1.52
  • 52 Week High $58.47
  • 52 Week Low $21.84
  • 50 Day Moving Average 46.47
  • 200 Day Moving Average 42.62
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Apellis Pharmaceuticals, Inc (APLS) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Apellis Pharmaceuticals, Inc (APLS) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-25$N/A$0.93-$0.45304.58%
2020-09-302020-11-02$646000-$1.79-$1.58-13.31%
2020-06-302020-07-30$N/A-$1.57-$1.34-17.56%
2020-03-312020-04-29$N/A-$2.29-$1.39-64.72%
2019-12-312020-02-27$N/A-$1.77-$1.14-55%
2019-09-302019-11-05$N/A-$1.10-$1.03-6.44%
2019-06-302019-07-31$N/A-$1.12-$0.78-44.39%
2019-03-312019-05-07$N/A-$0.87-$0.68-27.49%
2018-12-312019-02-26$N/A-$0.65-$0.707.58%
2018-09-302018-11-13$N/A-$0.64-$0.697.02%
2018-06-302018-07-31$N/A-$0.61-$0.42-45.86%
2018-03-312018-04-30$N/A-$0.43-$0.27-57.28%
2017-12-312018-03-19$N/A-$0.61-$0.27-129.32%
2017-09-302017-12-20$N/A-$0.23-$0.242.75%

Apellis Pharmaceuticals, Inc (APLS) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Apellis Pharmaceuticals, Inc (APLS) Chart:

Apellis Pharmaceuticals, Inc (APLS) News:

Below you will find a list of latest news for Apellis Pharmaceuticals, Inc (APLS) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Apellis Pharmaceuticals, Inc (APLS) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2026-05-15100CALL0 0960.2TRUE00
2026-05-15110CALL0 0897.66TRUE00
2026-05-15120CALL0 0841.37TRUE00
2026-05-15130CALL0 0790.21TRUE00
2026-05-15140CALL0 0743.3TRUE00
2026-05-15150CALL0 0699.98TRUE00
2026-05-15160CALL0 0659.73TRUE00
2026-05-15170CALL0 0622.12TRUE00
2026-05-15180CALL0 15493.73TRUE00
2026-05-15190CALL0 4464.94TRUE00
2026-05-15200CALL0 2670TRUE00
2026-05-15210CALL0 0380.98TRUE00
2026-05-15220CALL0 20TRUE00
2026-05-15230CALL0 100TRUE00
2026-05-152417.03CALL1 4150.62TRUE17.030
2026-05-152516.12CALL1 0248.34TRUE16.120
2026-05-15260CALL0 00TRUE00
2026-05-15270CALL0 00TRUE00
2026-05-15280CALL0 0156.94TRUE00
2026-05-15290CALL0 0143.57TRUE00
2026-05-15300CALL0 0176.07TRUE00
2026-05-15310CALL0 0144.73TRUE00
2026-05-15320CALL0 0145.2TRUE00
2026-05-15330CALL0 0130.24TRUE00
2026-05-15340CALL0 0115.53TRUE00
2026-05-15350CALL0 0101TRUE00
2026-05-15364.8CALL0 159.63TRUE00
2026-05-15370CALL0 068.03TRUE00
2026-05-15380CALL0 054.08TRUE00
2026-05-15390CALL0 00TRUE00
2026-05-15401.1CALL0 13115.05TRUE00
2026-05-15410.05CALL2 40711.65TRUE00
2026-05-15420CALL0 115.8FALSE00
2026-05-15430CALL0 027.16FALSE00
2026-05-15440CALL0 037.42FALSE00
2026-05-15450CALL0 247FALSE00
2026-05-15460CALL0 056.05FALSE00
2026-05-15470CALL0 0118.22FALSE00
2026-05-15480CALL0 072.96FALSE00
2026-05-15490CALL0 080.92FALSE00
2026-05-15500CALL0 188.59FALSE00
2026-05-15550CALL0 0123.58FALSE00
2026-05-15600CALL0 0154.17FALSE00
2026-05-15100PUT0 0546.87FALSE00
2026-05-15110PUT0 0511.03FALSE00
2026-05-15120PUT0 0478.44FALSE00
2026-05-15130PUT0 0448.57FALSE00
2026-05-15140PUT0 0420.99FALSE00
2026-05-15150PUT0 66395.36FALSE00
2026-05-15160PUT0 0987.29FALSE00
2026-05-15170PUT0 9348.95FALSE00
2026-05-15180PUT0 0327.78FALSE00
2026-05-15190PUT0 0835.73FALSE00
2026-05-15200PUT0 10288.73FALSE00
2026-05-15210PUT0 0270.63FALSE00
2026-05-15220PUT0 0253.34FALSE00
2026-05-15230PUT0 10236.78FALSE00
2026-05-15240PUT0 15220.9FALSE00
2026-05-15250PUT0 2800205.61FALSE00
2026-05-15260PUT0 66190.88FALSE00
2026-05-15270PUT0 18176.64FALSE00
2026-05-15280PUT0 0162.85FALSE00
2026-05-15290PUT0 0149.47FALSE00
2026-05-15300PUT0 328136.47FALSE00
2026-05-15310PUT0 0123.8FALSE00
2026-05-15320PUT0 0111.42FALSE00
2026-05-15330PUT0 599.31FALSE00
2026-05-15340PUT0 087.41FALSE00
2026-05-15350PUT0 391275.7FALSE00
2026-05-15360PUT0 7264.12FALSE00
2026-05-15370PUT0 3452.6FALSE00
2026-05-15380PUT0 1541.06FALSE00
2026-05-15390PUT0 3129.34FALSE00
2026-05-15400.04PUT10 53119.28FALSE0.040
2026-05-15410PUT0 22.31FALSE00
2026-05-15420PUT0 065.04TRUE00
2026-05-15430PUT0 068.05TRUE00
2026-05-15442.91PUT0 054.92TRUE00
2026-05-15450PUT0 0141.69TRUE00
2026-05-15460PUT0 0101.72TRUE00
2026-05-15470PUT0 0114.14TRUE00
2026-05-15480PUT0 0125.93TRUE00
2026-05-15490PUT0 0137.17TRUE00
2026-05-15500PUT0 0153.76TRUE00
2026-05-15550PUT0 0247.23TRUE00
2026-05-15600PUT0 0298.89TRUE00
2026-06-18330CALL0 00TRUE00
2026-06-18340CALL0 032.29TRUE00
2026-06-18350CALL0 032.01TRUE00
2026-06-18360CALL0 00TRUE00
2026-06-18370CALL0 00TRUE00
2026-06-18380CALL0 00TRUE00
2026-06-18390CALL0 014.22TRUE00
2026-06-18401.15CALL0 340TRUE00
2026-06-18410.05CALL0 832.2TRUE00
2026-06-18420.05CALL20 45.54FALSE00
2026-06-18430CALL0 08.3FALSE00
2026-06-18440CALL0 011.66FALSE00
2026-06-18450.03CALL10 015.27FALSE0.030
2026-06-18460CALL0 017.73FALSE00
2026-06-18470CALL0 020.54FALSE00
2026-06-18480CALL0 023.24FALSE00
2026-06-18490CALL0 025.83FALSE00
2026-06-18330PUT0 032.63FALSE00
2026-06-18340PUT0 074.31FALSE00
2026-06-18350PUT0 2624.99FALSE00
2026-06-18360PUT0 060.07FALSE00
2026-06-18370PUT0 052.93FALSE00
2026-06-18380.06PUT0 6013.78FALSE00
2026-06-18390PUT0 010FALSE00
2026-06-18400PUT0 06.06FALSE00
2026-06-18410.05PUT35 01.95FALSE0.050
2026-06-18420PUT0 031.76TRUE00
2026-06-18430PUT0 026.11TRUE00
2026-06-18440PUT0 026.39TRUE00
2026-06-18450PUT0 031.95TRUE00
2026-06-18460PUT0 038.66TRUE00
2026-06-18470PUT0 044.51TRUE00
2026-06-18480PUT0 047.26TRUE00
2026-06-18490PUT0 052.8TRUE00
2026-07-17100CALL0 0183.69TRUE00
2026-07-17120CALL0 2159.12TRUE00
2026-07-17130CALL0 1148.46TRUE00
2026-07-17140CALL0 0138.67TRUE00
2026-07-17150CALL0 0129.6TRUE00
2026-07-17160CALL0 0121.17TRUE00
2026-07-17170CALL0 1113.27TRUE00
2026-07-17180CALL0 0105.86TRUE00
2026-07-17190CALL0 098.88TRUE00
2026-07-17200CALL0 3692.27TRUE00
2026-07-17210CALL0 586TRUE00
2026-07-17220CALL0 180.04TRUE00
2026-07-17230CALL0 2774.36TRUE00
2026-07-17240CALL0 668.92TRUE00
2026-07-17250CALL0 863.72TRUE00
2026-07-17260CALL0 1858.73TRUE00
2026-07-17270CALL0 053.94TRUE00
2026-07-17280CALL0 4249.32TRUE00
2026-07-17290CALL0 044.87TRUE00
2026-07-17300CALL0 640.58TRUE00
2026-07-17310CALL0 136.43TRUE00
2026-07-17320CALL0 132.41TRUE00
2026-07-17330CALL0 228.52TRUE00
2026-07-17340CALL0 024.75TRUE00
2026-07-17350CALL0 30TRUE00
2026-07-17360CALL0 026.47TRUE00
2026-07-17370CALL0 00TRUE00
2026-07-17380CALL0 00TRUE00
2026-07-17390CALL0 00TRUE00
2026-07-17400CALL0 5570TRUE00
2026-07-17410.05CALL0 50130TRUE00
2026-07-17420CALL0 13.05FALSE00
2026-07-17430CALL0 15.92FALSE00
2026-07-17440CALL0 029.82FALSE00
2026-07-17450CALL0 034.1FALSE00
2026-07-17460CALL0 038.07FALSE00
2026-07-17470CALL0 041.79FALSE00
2026-07-17480CALL0 045.3FALSE00
2026-07-17490CALL0 048.63FALSE00
2026-07-17500CALL0 051.81FALSE00
2026-07-17550CALL0 065.89FALSE00
2026-07-17600CALL0 137.13FALSE00
2026-07-17100PUT0 0134.17FALSE00
2026-07-17120PUT0 0234.35FALSE00
2026-07-17130PUT0 1110.15FALSE00
2026-07-17140PUT0 3103.41FALSE00
2026-07-17150PUT0 197.14FALSE00
2026-07-17160PUT0 191.29FALSE00
2026-07-17170PUT0 185.8FALSE00
2026-07-17180PUT0 380.63FALSE00
2026-07-17190PUT0 1275.74FALSE00
2026-07-17200PUT0 6671.09FALSE00
2026-07-17210PUT0 1966.67FALSE00
2026-07-17220PUT0 3562.44FALSE00
2026-07-17230PUT0 10458.4FALSE00
2026-07-17240PUT0 4359.94FALSE00
2026-07-17250PUT0 17459.5FALSE00
2026-07-17260PUT0 755.39FALSE00
2026-07-17270PUT0 054.01FALSE00
2026-07-17280PUT0 750.01FALSE00
2026-07-17290PUT0 146.12FALSE00
2026-07-17300.05PUT0 228742.34FALSE00
2026-07-17310PUT0 1041.92FALSE00
2026-07-17320PUT0 239.4FALSE00
2026-07-17330PUT0 535.54FALSE00
2026-07-17340PUT0 132.79FALSE00
2026-07-17350.05PUT0 43819.09FALSE00
2026-07-17360PUT0 3225.13FALSE00
2026-07-17370PUT0 7024.15FALSE00
2026-07-17380PUT0 510.67FALSE00
2026-07-17390.18PUT0 567.83FALSE00
2026-07-17400.05PUT8 4245.8FALSE0.050
2026-07-17410.01PUT200 1071.29FALSE0.010
2026-07-17420PUT0 024.74TRUE00
2026-07-17430PUT0 019.03TRUE00
2026-07-17440PUT0 022.48TRUE00
2026-07-17453.78PUT0 026.39TRUE00
2026-07-17460PUT0 031.53TRUE00
2026-07-17470PUT0 036.03TRUE00
2026-07-17480PUT0 038.32TRUE00
2026-07-17490PUT0 041.47TRUE00
2026-07-17500PUT0 044.48TRUE00
2026-07-17550PUT0 056.6TRUE00
2026-07-17600PUT0 068.01TRUE00
2026-10-16100CALL0 0126.06TRUE00
2026-10-16120CALL0 0107.99TRUE00
2026-10-16130CALL0 0104.1TRUE00
2026-10-16140CALL0 096.78TRUE00
2026-10-16150CALL0 093.41TRUE00
2026-10-16160CALL0 087.04TRUE00
2026-10-16170CALL0 081.08TRUE00
2026-10-16180CALL0 075.48TRUE00
2026-10-16190CALL0 070.2TRUE00
2026-10-16200CALL0 465.2TRUE00
2026-10-16210CALL0 063.22TRUE00
2026-10-16220CALL0 058.68TRUE00
2026-10-16230CALL0 054.34TRUE00
2026-10-162417CALL0 350.2TRUE00
2026-10-16250CALL0 046.23TRUE00
2026-10-16260CALL0 042.42TRUE00
2026-10-16270CALL0 041.04TRUE00
2026-10-16280CALL0 1249.59TRUE00
2026-10-16290CALL0 134.09TRUE00
2026-10-16300CALL0 130.79TRUE00
2026-10-16310CALL0 027.61TRUE00
2026-10-16320CALL0 024.52TRUE00
2026-10-16330CALL0 023.36TRUE00
2026-10-16340CALL0 020.44TRUE00
2026-10-16350CALL0 117.61TRUE00
2026-10-16360CALL0 014.86TRUE00
2026-10-16370CALL0 00TRUE00
2026-10-16380CALL0 05.61TRUE00
2026-10-16390CALL0 010.37TRUE00
2026-10-16401.15CALL0 370TRUE00
2026-10-16410CALL0 46020TRUE00
2026-10-16420.05CALL4 151.49FALSE00
2026-10-16430CALL0 015.03FALSE00
2026-10-16440CALL0 018.21FALSE00
2026-10-16450CALL0 08.06FALSE00
2026-10-16460CALL0 023.72FALSE00
2026-10-16470CALL0 026.19FALSE00
2026-10-16480CALL0 028.5FALSE00
2026-10-16490CALL0 030.7FALSE00
2026-10-16500CALL0 032.8FALSE00
2026-10-16550CALL0 042.05FALSE00
2026-10-16600CALL0 023.67FALSE00
2026-10-16100PUT0 087.9FALSE00
2026-10-16120PUT0 0153.58FALSE00
2026-10-16130PUT0 072.24FALSE00
2026-10-16140PUT0 0135.94FALSE00
2026-10-16150PUT0 463.77FALSE00
2026-10-16160PUT0 0121FALSE00
2026-10-16170PUT0 556.39FALSE00
2026-10-16180PUT0 058.01FALSE00
2026-10-16190PUT0 354.55FALSE00
2026-10-16200PUT0 051.28FALSE00
2026-10-16210PUT0 148.16FALSE00
2026-10-16220PUT0 045.18FALSE00
2026-10-16230PUT0 344.99FALSE00
2026-10-16240PUT0 076.69FALSE00
2026-10-16250PUT0 4139.33FALSE00
2026-10-16260PUT0 038.48FALSE00
2026-10-16270PUT0 037.26FALSE00
2026-10-16280PUT0 035.81FALSE00
2026-10-16290PUT0 055.93FALSE00
2026-10-16300PUT0 931.51FALSE00
2026-10-16310PUT0 048.44FALSE00
2026-10-16320PUT0 044.81FALSE00
2026-10-16330PUT0 041.25FALSE00
2026-10-16340PUT0 037.38FALSE00
2026-10-16350.05PUT2 18114.57FALSE0.050
2026-10-16360PUT0 016.52FALSE00
2026-10-16370PUT0 027.34FALSE00
2026-10-16380PUT0 07.53FALSE00
2026-10-16390PUT0 05.69FALSE00
2026-10-16400.05PUT84 794.44FALSE0.050
2026-10-16410.1PUT0 231.26FALSE00
2026-10-16420PUT0 017.65TRUE00
2026-10-16430PUT0 013.88TRUE00
2026-10-16440PUT0 016.65TRUE00
2026-10-16450PUT0 019.4TRUE00
2026-10-16460PUT0 022.93TRUE00
2026-10-16470PUT0 026.03TRUE00
2026-10-16480PUT0 027.69TRUE00
2026-10-16490PUT0 029.89TRUE00
2026-10-16500PUT0 032TRUE00
2026-10-16550PUT0 040.6TRUE00
2026-10-16600PUT0 048.64TRUE00
2027-01-1550CALL0 0142.68TRUE00
2027-01-15100CALL0 1788.52TRUE00
2027-01-15130CALL0 064.06TRUE00
2027-01-15150CALL0 43962.39TRUE00
2027-01-15180CALL0 149.94TRUE00
2027-01-15200CALL0 4844.24TRUE00
2027-01-15230CALL0 7525.37TRUE00
2027-01-152516.12CALL2 390TRUE16.120
2027-01-152812.4CALL0 3680TRUE00
2027-01-15300CALL0 2020TRUE00
2027-01-15330CALL0 20TRUE00
2027-01-15356.3CALL1 25120TRUE6.30
2027-01-15370CALL0 10TRUE00
2027-01-15401.05CALL15 13250TRUE1.050
2027-01-15420.05CALL3 33760FALSE0.050
2027-01-15450CALL0 496.26FALSE00
2027-01-15470CALL0 120.01FALSE00
2027-01-15500CALL0 5010.02FALSE00
2027-01-15550CALL0 60914.52FALSE00
2027-01-15600CALL0 018.44FALSE00
2027-01-1550PUT0 0104.39FALSE00
2027-01-15100PUT0 770.44FALSE00
2027-01-15130PUT0 057.97FALSE00
2027-01-15150PUT0 38951.22FALSE00
2027-01-15180PUT0 1142.65FALSE00
2027-01-15200PUT0 19941.3FALSE00
2027-01-15230.05PUT0 238.04FALSE00
2027-01-15250PUT0 77529.89FALSE00
2027-01-15280PUT0 929.96FALSE00
2027-01-15300PUT0 64318.44FALSE00
2027-01-15330PUT0 524.99FALSE00
2027-01-15350PUT0 65010.79FALSE00
2027-01-15370.05PUT0 5927.89FALSE00
2027-01-15400.05PUT1 11174.03FALSE-0.02-0.29
2027-01-15420PUT0 177.08TRUE00
2027-01-15450PUT0 013.87TRUE00
2027-01-15470PUT0 018.48TRUE00
2027-01-15500PUT0 025.74TRUE00
2027-01-15550PUT0 034.82TRUE00
2027-01-15600PUT0 040.12TRUE00
2028-01-2130CALL0 00TRUE00
2028-01-2150CALL0 00TRUE00
2028-01-21100CALL0 50TRUE00
2028-01-21130CALL0 30TRUE00
2028-01-21150CALL0 00TRUE00
2028-01-21180CALL0 10TRUE00
2028-01-21200CALL0 70TRUE00
2028-01-21220CALL0 00TRUE00
2028-01-21250CALL0 20TRUE00
2028-01-21270CALL0 20TRUE00
2028-01-21300CALL0 20TRUE00
2028-01-21320CALL0 190TRUE00
2028-01-21350CALL0 1210TRUE00
2028-01-21370CALL0 00TRUE00
2028-01-21401.06CALL10 10020TRUE-0.04-0.04
2028-01-21420.06CALL0 850FALSE00
2028-01-21450CALL0 4161.53FALSE00
2028-01-21470CALL0 03.93FALSE00
2028-01-21500CALL0 021.31FALSE00
2028-01-21550CALL0 08.1FALSE00
2028-01-21600CALL0 211.71FALSE00
2028-01-2130PUT0 084.02FALSE00
2028-01-2150PUT0 067.28FALSE00
2028-01-21100PUT0 045.71FALSE00
2028-01-21130PUT0 041.24FALSE00
2028-01-21150PUT0 2536.59FALSE00
2028-01-21180PUT0 2030.7FALSE00
2028-01-21200PUT0 030.28FALSE00
2028-01-21220PUT0 525.71FALSE00
2028-01-21250PUT0 024.74FALSE00
2028-01-21270PUT0 822.34FALSE00
2028-01-21300PUT0 15418.57FALSE00
2028-01-21320PUT0 1114.53FALSE00
2028-01-21350.05PUT1 298.82FALSE0.050
2028-01-21370PUT0 1076.07FALSE00
2028-01-21400.05PUT525 18103.59FALSE-0.05-0.5
2028-01-21420PUT0 5015.77TRUE00
2028-01-21450PUT0 00TRUE00
2028-01-21470PUT0 015.5TRUE00
2028-01-21500PUT0 019.03TRUE00
2028-01-21550PUT0 024.57TRUE00
2028-01-21600PUT0 028.63TRUE00

Latest APLS Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST5$39.4
Jun 13, 2022 7:59 PM EST25$39.4
Jun 13, 2022 7:59 PM EST86$39.39
Jun 13, 2022 7:59 PM EST14$39.4
Jun 13, 2022 7:59 PM EST32$39.4

Apellis Pharmaceuticals, Inc (APLS) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220021048/0001127602-20-021048-index.htm
2020-02-05SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1492422/000083423720004741/0000834237-20-004741-index.htm
2020-02-053/AInitial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320003295/0000899243-20-003295-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004260/0000899243-20-004260-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004262/0000899243-20-004262-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004264/0000899243-20-004264-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004268/0000899243-20-004268-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004275/0000899243-20-004275-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004281/0000899243-20-004281-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004288/0000899243-20-004288-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004299/0000899243-20-004299-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004303/0000899243-20-004303-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004312/0000899243-20-004312-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004314/0000899243-20-004314-index.htm
2020-03-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320008068/0000899243-20-008068-index.htm
2020-10-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320027595/0000899243-20-027595-index.htm
2020-10-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320027598/0000899243-20-027598-index.htm
2020-02-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1492422/000090221920000352/0000902219-20-000352-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1492422/000090266420001196/0000902664-20-001196-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1492422/000092963820000336/0000929638-20-000336-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220005685/0001127602-20-005685-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220006429/0001127602-20-006429-index.htm
2020-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220006654/0001127602-20-006654-index.htm
2020-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-03-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220011988/0001127602-20-011988-index.htm
2020-04-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220013334/0001127602-20-013334-index.htm
2020-04-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220013338/0001127602-20-013338-index.htm
2020-04-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220014098/0001127602-20-014098-index.htm
2020-04-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220014100/0001127602-20-014100-index.htm
2020-04-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220014554/0001127602-20-014554-index.htm
2020-05-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220016304/0001127602-20-016304-index.htm
2020-05-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220017178/0001127602-20-017178-index.htm
2020-05-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220017181/0001127602-20-017181-index.htm
2020-06-093Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220019258/0001127602-20-019258-index.htm
2020-06-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220019731/0001127602-20-019731-index.htm
2020-06-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220019733/0001127602-20-019733-index.htm
2020-06-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220019735/0001127602-20-019735-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220021048/0001127602-20-021048-index.htm
2020-07-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220021646/0001127602-20-021646-index.htm
2020-08-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220022885/0001127602-20-022885-index.htm
2020-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220023992/0001127602-20-023992-index.htm
2020-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220024043/0001127602-20-024043-index.htm
2020-09-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220024640/0001127602-20-024640-index.htm
2020-09-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220025183/0001127602-20-025183-index.htm
2020-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220026264/0001127602-20-026264-index.htm
2020-10-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220026748/0001127602-20-026748-index.htm
2020-10-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220026750/0001127602-20-026750-index.htm
2020-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220027098/0001127602-20-027098-index.htm
2020-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220027101/0001127602-20-027101-index.htm
2020-11-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220027991/0001127602-20-027991-index.htm
2020-02-27S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1492422/000119312520052855/0001193125-20-052855-index.htm
2020-02-27S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1492422/000119312520052867/0001193125-20-052867-index.htm
2020-04-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1492422/000119312520098977/0001193125-20-098977-index.htm
2020-04-22DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1492422/000119312520115068/0001193125-20-115068-index.htm
2020-04-22DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1492422/000119312520115084/0001193125-20-115084-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1492422/000119312520135621/0001193125-20-135621-index.htm
2020-05-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1492422/000119312520141579/0001193125-20-141579-index.htm
2020-06-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1492422/000119312520157384/0001193125-20-157384-index.htm
2020-10-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1492422/000119312520277496/0001193125-20-277496-index.htm
2010-05-19DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1492242/000149224210000001/0001492242-10-000001-index.htm
2020-02-2710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1492422/000156459020007350/0001564590-20-007350-index.htm
2020-04-2910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1492422/000156459020019689/0001564590-20-019689-index.htm
2020-07-3010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1492422/000156459020034763/0001564590-20-034763-index.htm
2020-11-0210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1492422/000156459020049423/0001564590-20-049423-index.htm
2020-08-24CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1492422/999999999720004458/9999999997-20-004458-index.htm

Apellis Pharmaceuticals, Inc (APLS) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Apellis Pharmaceuticals, Inc (APLS). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 2117%
Institutional Ownership: 8285%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-02-13Pascal DeschateletsChief Operating OfficerSell55,398.0040.982,270,154.641,008,681.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220005685/0001127602-20-005685-index.htm
2020-02-18Cedric FrancoisChief Executive OfficerSell5,000.0040.67203,330.001,027,430.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220006654/0001127602-20-006654-index.htm
2020-02-18Cedric FrancoisChief Executive OfficerSell30,637.0040.661,245,792.331,032,430.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220006654/0001127602-20-006654-index.htm
2020-03-16Cedric FrancoisChief Executive OfficerSell300.0023.867,158.001,053,067.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-03-16Cedric FrancoisChief Executive OfficerSell3,212.0022.2871,556.941,053,367.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-03-16Cedric FrancoisChief Executive OfficerSell15,065.0021.58325,087.641,056,579.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-02-19Cedric FrancoisChief Executive OfficerBuy30,637.002.1465,563.181,058,067.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220006654/0001127602-20-006654-index.htm
2020-02-18Cedric FrancoisChief Executive OfficerBuy30,637.002.1465,563.181,063,067.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220006654/0001127602-20-006654-index.htm
2020-02-13Pascal DeschateletsChief Operating OfficerBuy117,205.002.14250,818.701,064,079.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220005685/0001127602-20-005685-index.htm
2020-02-10Cedric FrancoisChief Executive OfficerBuy34,375.001,066,805.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004299/0000899243-20-004299-index.htm
2020-03-16Cedric FrancoisChief Executive OfficerSell12,060.0020.69249,557.581,071,644.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-10-15Cedric FrancoisChief Executive OfficerSell5,000.0034.46172,300.001,083,079.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220027098/0001127602-20-027098-index.htm
2020-03-17Cedric FrancoisChief Executive OfficerBuy30,637.002.1465,563.181,083,704.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-03-16Cedric FrancoisChief Executive OfficerSell700.0022.2915,600.201,083,704.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-03-16Cedric FrancoisChief Executive OfficerSell2,192.0021.5747,279.251,084,404.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-03-16Cedric FrancoisChief Executive OfficerSell2,108.0020.7343,694.621,086,596.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-09-15Cedric FrancoisChief Executive OfficerSell5,000.0030.96154,800.001,088,079.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220025183/0001127602-20-025183-index.htm
2020-03-16Cedric FrancoisChief Executive OfficerBuy30,637.002.1465,563.181,088,704.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-08-20Cedric FrancoisChief Executive OfficerSell3,457.0030.00103,710.001,093,079.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220024043/0001127602-20-024043-index.htm
2020-08-18Cedric FrancoisChief Executive OfficerSell1,543.0030.0046,290.001,096,536.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220023992/0001127602-20-023992-index.htm
2020-07-15Cedric FrancoisChief Executive OfficerSell5,000.0032.12160,600.001,098,079.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220021646/0001127602-20-021646-index.htm
2020-06-15Cedric FrancoisChief Executive OfficerSell5,000.0030.21151,050.001,103,079.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220019731/0001127602-20-019731-index.htm
2020-05-15Cedric FrancoisChief Executive OfficerSell5,000.0029.92149,600.001,108,079.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220017181/0001127602-20-017181-index.htm
2020-04-15Cedric FrancoisChief Executive OfficerSell5,000.0029.77148,850.001,113,079.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220014100/0001127602-20-014100-index.htm
2020-02-10LUKAS SCHEIBLEROfficerBuy9,375.0012,310.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004314/0000899243-20-004314-index.htm
2020-10-07Victoria L. BrownProgram Team LeadBuy12,000.0018.98227,760.0015,607.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220026748/0001127602-20-026748-index.htm
2020-02-10Timothy Eugene SullivanChief Financial OfficerBuy11,688.0023,387.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004303/0000899243-20-004303-index.htm
2020-02-10Nicole D PerryVice President - FinanceBuy2,500.002,500.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004275/0000899243-20-004275-index.htm
2020-02-10Ahmad SadrOfficerBuy2,725.002,725.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004264/0000899243-20-004264-index.htm
2020-11-02Federico GrossiCHIEF MEDICAL OFFICERSell600.0031.0918,654.0027,725.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220027991/0001127602-20-027991-index.htm
2020-10-01Federico GrossiOfficerSell600.0030.2218,132.0028,325.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220026264/0001127602-20-026264-index.htm
2020-09-01Federico GrossiOfficerSell600.0031.5818,948.0028,925.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220024640/0001127602-20-024640-index.htm
2020-08-03Federico GrossiOfficerSell600.0026.2815,768.0029,525.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220022885/0001127602-20-022885-index.htm
2020-07-01Federico GrossiOfficerSell850.0032.4327,565.5030,125.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220021048/0001127602-20-021048-index.htm
2020-06-15Federico GrossiOfficerSell856.0030.2125,859.7630,975.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220019735/0001127602-20-019735-index.htm
2020-02-10Federico GrossiOfficerBuy9,375.0031,831.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004262/0000899243-20-004262-index.htm
2020-02-10David O. WatsonGeneral CounselSell5,000.0044.50222,500.0035,417.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004260/0000899243-20-004260-index.htm
2020-10-07Victoria L. BrownProgram Team LeadSell12,000.0035.00420,000.003,607.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220026748/0001127602-20-026748-index.htm
2020-02-10David O. WatsonGeneral CounselBuy6,375.0040,417.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004260/0000899243-20-004260-index.htm
2020-02-10David O. WatsonGeneral CounselBuy7,505.002.6720,038.3542,922.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004260/0000899243-20-004260-index.htm
2020-05-08PAUL R. FONTEYNEDirectorBuy5,000.0031.81159,034.005,000.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220016304/0001127602-20-016304-index.htm
2020-02-10Lucia CelonaOfficerBuy5,213.005,213.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004281/0000899243-20-004281-index.htm
2020-02-14Alec MachielsDirectorSell2,500.0042.35105,875.00669,544.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220006429/0001127602-20-006429-index.htm
2020-03-25Alec MachielsDirectorSell2,500.0030.0075,000.00669,544.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011988/0001127602-20-011988-index.htm
2020-04-15Alec MachielsDirectorSell2,500.0030.0075,000.00669,544.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220014098/0001127602-20-014098-index.htm
2020-05-15Alec MachielsDirectorSell2,500.0030.0075,000.00669,544.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220017178/0001127602-20-017178-index.htm
2020-06-15Alec MachielsDirectorSell2,500.0030.2175,525.00669,544.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220019733/0001127602-20-019733-index.htm
2020-10-07Alec MachielsDirectorSell7,500.0035.00262,500.00669,544.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220026750/0001127602-20-026750-index.htm
2020-10-15Alec MachielsDirectorSell2,500.0035.0087,500.00669,544.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220027101/0001127602-20-027101-index.htm
2020-02-14Alec MachielsDirectorBuy2,500.002.676,675.00672,044.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220006429/0001127602-20-006429-index.htm
2020-03-25Alec MachielsDirectorBuy2,500.002.676,675.00672,044.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011988/0001127602-20-011988-index.htm
2020-04-15Alec MachielsDirectorBuy2,500.002.676,675.00672,044.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220014098/0001127602-20-014098-index.htm
2020-05-15Alec MachielsDirectorBuy2,500.002.676,675.00672,044.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220017178/0001127602-20-017178-index.htm
2020-06-15Alec MachielsDirectorBuy2,500.002.676,675.00672,044.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220019733/0001127602-20-019733-index.htm
2020-10-15Alec MachielsDirectorBuy2,500.002.676,675.00672,044.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220027101/0001127602-20-027101-index.htm
2020-10-07Alec MachielsDirectorBuy7,500.002.6720,025.00677,044.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220026750/0001127602-20-026750-index.htm
2020-02-10Thomas A. LacknerOfficerBuy2,725.007,725.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004268/0000899243-20-004268-index.htm
2020-02-10Pascal DeschateletsChief Operating OfficerBuy9,375.00891,118.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004312/0000899243-20-004312-index.htm
2020-02-10Adam J. TownsendOfficerBuy9,375.009,375.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004288/0000899243-20-004288-index.htm
2020-02-12Pascal DeschateletsChief Operating OfficerSell52,075.0042.802,228,966.23946,874.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220005685/0001127602-20-005685-index.htm
2020-02-12Pascal DeschateletsChief Operating OfficerBuy117,206.002.14250,820.84998,949.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220005685/0001127602-20-005685-index.htm